Search

everythinglearnresearchcommunity

for

Search:↓

China approved Sinovac's flu vaccine, Japan approved RiUP for female hair loss, and Nippon Kayaku's three cancer drugs.

Statins can reduce androgen levels and improve symptoms in women with PCOS.

Finasteride increases risk of sleep apnea and insomnia.

Azithromycin and Roxithromycin can remove aging cells and may help with anti-aging.

Finasteride helps induce ovulation in nonresponder PCOS women.

Mesotherapy with bicalutamide has limited effectiveness for female hair loss.

Most patients with frontal fibrosing alopecia are postmenopausal women, and treatments like finasteride and dutasteride can improve or stabilize the condition.

Low-dose oral minoxidil improves hair loss and quality of life for women, despite mild side effects.

Minoxidil is the only drug proven to improve female hair loss, and dextroamphetamine sulfate may be a new treatment for certain types of hair loss.

Estrogen-progestin contraception lowers ovarian, endometrial, and colon cancer risk but may raise breast and cervical cancer risk, helps with menstrual and acne issues, and new methods are as effective as pills. Metformin helps overweight women with PCOS and insulin resistance, and dopamine agonists treat prolactinomas.

Combination therapy with steroids and pimecrolimus improved or stabilized hair loss in most patients with Frontal Fibrosing Alopecia, who also had a high rate of hypothyroidism.

A 14-year-old girl with Loose Anagen Hair Syndrome was successfully treated with oral Minoxidil and a Silicon supplement.

JAK inhibitors, like ruxolitinib, may effectively treat frontal fibrosing alopecia.

Local hormonal treatment for vulvovaginal atrophy is likely safe for women with estrogen receptor-positive breast cancer on aromatase inhibitors.

Plant extracts effectively reduce hair loss and increase growth, offering a safe alternative treatment.

Low-dose naltrexone might be a cheap and effective additional treatment for hair loss with scalp discomfort due to its anti-inflammatory effects and few side effects.

Eflornithine cream effectively reduces women's unwanted facial hair but hair returns if treatment stops.

Spironolactone is safe for breast cancer survivors with alopecia and does not increase cancer risk.

More extensive trials are needed to understand tofacitinib's role in treating severe hair loss.

The food supplement with L-cystine, Serenoa repens extract, and biotin safely reduced hair loss and improved hair growth in men and women.

Combined finasteride and spironolactone therapy significantly improves quality of life in women with PCOS.

Finasteride reduces opioid use and withdrawal symptoms in animals.

Spironolactone use is not linked to an increased risk of breast cancer, but caution is advised for high-risk patients.

Finasteride and intense pulsed light effectively reduce unwanted facial hair in women, but may not be cost-effective.

Birth control pills can help reduce mild to moderate acne in women.

Early combination therapy can effectively regrow hair in frontal fibrosing alopecia.